Description
Bayer’s SUNHARBO® (asundexian), 50 mg tablets, the First and Only Factor XIa Inhibitor, Approved by the U.S. FDA to Reduce the Risk of Stroke in Adults With Recent Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack...
MORE INFORMATION:
https://www.businesswire.com/news/home/20261021770347/en/Bayers-SUNHARBO-asundexian-50-mg-tablets-the-First-and-Only-Factor-XIa-Inhibitor-Approved-by-the-U.S.-FDA-to-Reduce-the-Risk-of-Stroke-in-Adults-With-Recent-Non-Cardioembolic-Ischemic-Stroke-or-High-Risk-Transient-Ischemic-Attack...